Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
about
Transfusion Support for ABO-Incompatible Progenitor Cell TransplantationABO-Mismatched Allogeneic Hematopoietic Stem Cell TransplantationTransfusion medicine problems and solutions for the pediatric hematologist/oncologistPassenger lymphocyte syndrome and liver transplantationSafety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature review.A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantationRed blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation.Transfusion support issues in hematopoietic stem cell transplantation.A and B antigen levels acquired by group O donor-derived erythrocytes following ABO-non-identical transfusion or minor ABO-incompatible haematopoietic stem cell transplantation.A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.Passenger Lymphocyte Syndrome: A Case Report Involving Non-ABO Antibodies.ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditionFrequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning.IgM anti-recipient ABO antibodies predict acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.Successful management of sudden, massive immune hemolysis following ABO-incompatible allogeneic PBSCT despite methotrexate GvHD prophylaxis.Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation.ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation.Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT.A 'dangerous' group O donor: severe hemolysis in all recipients of organs from a donor with multiple red cell alloantibodies.Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation.
P2860
Q26750392-C55DA354-5AA3-4926-BD62-A83EAB50F0D6Q26750395-18E98D00-7544-4AC0-B486-E43B98895A71Q26851995-6C0A0FD8-6B27-40FC-BA00-207B47DEFE3EQ28237843-4BA071FD-D008-4086-88DB-E3B3E24782B5Q36266359-839754BE-FE59-4931-8978-FA1E96963994Q36746447-A68A45AC-EA35-4CD2-9F9B-1EEAC5CF350BQ36941032-2D3C920B-B67B-4B1F-98B2-9BB17AA602D5Q37928443-92BF64FB-1D5C-403F-B280-A06C0BD42F4EQ38287605-0673CB36-B1EE-4B3F-B788-EB1A18FA4ADAQ38841008-DEB2A0CA-A362-44AD-AF93-FD6A679738A4Q39441064-85C774A3-F850-4885-9447-68948F884519Q39715027-8D51AA50-FFDA-4E4C-A952-9265BB8EF9FEQ40456337-C12E37A9-B306-4F42-819E-F19E019A201AQ45172618-3F14E497-AE5C-478D-BBD9-BDCD1B5BF0B8Q45839863-AD44C8B5-7261-4D62-BDEB-8EEBCB81A20BQ46168868-48C6B294-B074-4ACE-8CC9-15296A94F8C1Q46772665-DFB708C0-C48A-40C4-97FA-4FB7B2ACD391Q47431505-4A8BEB32-DB72-4B51-85B0-9F37EFCA1A75Q47752542-8C11D14F-8AFD-413A-A096-13BDB1978A20Q50225112-4F7E9DE0-B255-40DA-B05C-6F9708FBE85EQ50448290-9356010E-EC99-4040-B783-6AD4308EB906Q50658464-8DF8220C-8436-46B7-9B35-569E2B3CA8BDQ50686421-018DC04A-1122-45A2-997D-36A09C5957CEQ53619723-FB833187-3BF1-4C4D-9227-019903B27705
P2860
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Severe immune hemolysis after ...... an myeloablative conditioning.
@en
Severe immune hemolysis after ...... an myeloablative conditioning.
@nl
type
label
Severe immune hemolysis after ...... an myeloablative conditioning.
@en
Severe immune hemolysis after ...... an myeloablative conditioning.
@nl
prefLabel
Severe immune hemolysis after ...... an myeloablative conditioning.
@en
Severe immune hemolysis after ...... an myeloablative conditioning.
@nl
P2093
P2860
P1433
P1476
Severe immune hemolysis after ...... an myeloablative conditioning.
@en
P2093
Felix Keil
Gottfried Fischer
Hildegard T Greinix
Klaus Lechner
Margit Mitterbauer
Nina Worel
Paul Höcker
Peter Kalhs
Wolfgang Mayr
P2860
P304
P356
10.1046/J.1537-2995.2002.00209.X
P577
2002-10-01T00:00:00Z